Skip to content
2000
Volume 5, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

Abstract

Background

Globally, urinary tract infections (UTIs) have attracted the attention of clinicians and have become a serious public health threat. Management of UTIs has become a growing concern for clinicians due to increased antimicrobial resistance (AMR). The present study was conducted to identify the most diagnosed uropathogens causing UTIs among Inpatient Department (IPD) and Outpatient Department (OPD) patients visiting a tertiary care health centre and also to analyse the patterns of prescribed antibiotics based on physicians’ empirical and urine culture-based approach. Furthermore, this study sought to evaluate the sensitivity patterns of selected bacteria against antibiotics used to treat UTIs among patients.

Methods

This study was undertaken for a period of three years at the Department of Medicine in collaboration with the Department of Microbiology. Mid-stream clean catch urine samples were collected from UTI suspects from both IPD and OPD patients and processed for culture and susceptibility testing as per standard guidelines. Univariate and bi-variate descriptive statistical techniques were used to analyse the data.

Results

A total of 2400 urine samples were processed for culture and sensitivity testing, out of which 200 samples were found positive. was the most frequently isolated urinary pathogen in both OPD and IPD patients (55.3% and 74.4%, respectively). Empirically, the most commonly prescribed antibiotic was piperacillin/tazobactam (13%), while the culture-based antibiotic was nitrofurantoin (20%). The findings highlight that more than 95% of isolates of the most prevalent uropathogen were sensitive to amikacin, ciprofloxacin, imipenem, and nitrofurantoin, whereas more than 90% were sensitive to ceftazidime, cefoperazone sulbactam, and piperacillin/tazobactam.

Conclusion

Increasing resistance to common antibiotics necessitates a reevaluation of both empirical and culture-based antibiotic approaches. The findings of this study are of significant importance and highlight the need to develop a targeted antibiogram for UTI, understand the trends in antimicrobial resistance (AMR), and ensure the rational selection and antibiogram both in empirical and culture-based approaches.

© 2024 The Author(s).
© 2024 The Author(s). Published by Bentham Science Publishers. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0102506882361055250328081507
2024-01-01
2025-10-31

  • From This Site

    /content/journals/nemj/10.2174/0102506882361055250328081507
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/nemj/5/1/NEMJ-5-E02506882361055.html?itemId=/content/journals/nemj/10.2174/0102506882361055250328081507&mimeType=html&fmt=ahah

References

  1. BarnawiY. AlghamdiA. IbrahimA. Al-AnaziL. AlhumaidaG. AlotaibiR. KhanM. BazD. AlraeyM. AlkazemiA. AlqhataniH. WaggasH. Prevalence of urinary tract infections in pregnant women and antimicrobial resistance patterns in women in Riyadh, Saudi Arabia: A retrospective study.BMC Infect. Dis.202424150210.1186/s12879‑024‑09385‑y38762526
     [Google Scholar]
  2. MishraM.P. SarangiR. PadhyR.N. Prevalence of multidrug resistant uropathogenic bacteria in pediatric patients of a tertiary care hospital in eastern India.J. Infect. Public Health20169330831410.1016/j.jiph.2015.10.00226617250
     [Google Scholar]
  3. TesfaT. BayeY. SisayM. AmareF. GashawT. Bacterial uropathogens and susceptibility testing among patients diagnosed with urinary tract infections at Hiwot Fana Specialized University Hospital, Eastern Ethiopia.SAGE Open Med.202192050312121100116210.1177/2050312121100116233796299
     [Google Scholar]
  4. Flores-MirelesA.L. WalkerJ.N. CaparonM. HultgrenS.J. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options.Nat. Rev. Microbiol.201513526928410.1038/nrmicro343225853778
     [Google Scholar]
  5. AlzohairyM. Frequency and antibiotic susceptibility pattern of uro-pathogens isolated from community and hospital-acquired infections in Saudi Arabia: A prospective case study.Br. J. Med. Med. Res.201112455610.9734/BJMMR/2011/207
     [Google Scholar]
  6. BaralP. NeupaneS. MarasiniB.P. GhimireK.R. LekhakB. ShresthaB. High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal.BMC Res. Notes2012513810.1186/1756‑0500‑5‑3822260454
     [Google Scholar]
  7. WalkerE. LymanA. GuptaK. MahoneyM.V. SnyderG.M. HirschE.B. Clinical management of an increasing threat: Outpatient urinary tract infections due to multidrug-resistant uropathogens: Table 1.Clin. Infect. Dis.201663796096510.1093/cid/ciw39627313263
     [Google Scholar]
  8. ZowawiH.M. HarrisP.N.A. RobertsM.J. TambyahP.A. SchembriM.A. PezzaniM.D. WilliamsonD.A. PatersonD.L. The emerging threat of multidrug-resistant Gram-negative bacteria in urology.Nat. Rev. Urol.2015121057058410.1038/nrurol.2015.19926334085
     [Google Scholar]
  9. ChooramaniG. JainB. ChauhanP.S. Prevalence and antimicrobial sensitivity pattern of bacteria causing urinary tract infection; study of a tertiary care hospital in North India.Clin. Epidemiol. Glob. Health20208389089310.1016/j.cegh.2020.02.018
     [Google Scholar]
  10. AljohaniR.H. ElFekyD.S. AlswajiA.A. AlrashidiE. OkdahL. AlalwanB. AljohaniS.M. BalkhyH.H. RedhwanA. AlghoribiM.F. Genomic characterization of uropathogenic Escherichia coli isolates from tertiary hospitals in Riyadh, Saudi Arabia.Int. J. Mol. Sci.2023248758210.3390/ijms2408758237108743
     [Google Scholar]
  11. KucheriaR. DasguptaP. SacksS.H. KhanM.S. SheerinN.S. Urinary tract infections: New insights into a common problem.Postgrad. Med. J.200581952838610.1136/pgmj.2004.02303615701738
     [Google Scholar]
  12. KahsayT. GebrehiwotG.T. GebreyohannesG. TilahunM. GesseseA. KahsayA. Antimicrobial susceptibility patterns of urinary tract infections causing bacterial isolates and associated risk factors among HIV patients in Tigray, Northern Ethiopia.BMC Microbiol.202424114810.1186/s12866‑024‑03297‑238678188
     [Google Scholar]
  13. EffahC.Y. SunT. LiuS. WuY. Klebsiella pneumoniae: An increasing threat to public health.Ann. Clin. Microbiol. Antimicrob.20201911910.1186/s12941‑019‑0343‑831918737
     [Google Scholar]
  14. Navon-VeneziaS. KondratyevaK. CarattoliA. Klebsiella pneumoniae: A major worldwide source and shuttle for antibiotic resistance.FEMS Microbiol. Rev.201741325227510.1093/femsre/fux01328521338
     [Google Scholar]
  15. FerreiraR.L. da SilvaB.C.M. RezendeG.S. Nakamura-SilvaR. Pitondo-SilvaA. CampaniniE.B. BritoM.C.A. da SilvaE.M.L. FreireC.C.M. CunhaA.F. PrancheviciusM.C.S. High prevalence of multidrug-resistant Klebsiella pneumoniae harboring several virulence and β-lactamase encoding genes in a brazilian intensive care unit.Front. Microbiol.20199319810.3389/fmicb.2018.0319830723463
     [Google Scholar]
  16. ShararaS.L. AmoahJ. PanaZ.D. SimnerP.J. CosgroveS.E. TammaP.D. Is piperacillin-tazobactam effective for the treatment of pyelonephritis caused by extended-spectrum β-lactamase–producing organisms?Clin. Infect. Dis.2020718e331e33710.1093/cid/ciz120531859352
     [Google Scholar]
  17. SeoY.B. LeeJ. KimY.K. LeeS.S. LeeJ. KimH.Y. UhY. KimH.S. SongW. Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.BMC Infect. Dis.201717140410.1186/s12879‑017‑2502‑x28592240
     [Google Scholar]
  18. XinX. JianL. XiaX. JiaB. HuangW. LiC. WangC. ZhouL. SunX. TangX. HuangY. ZhuY. ZhangW. A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.Ann. Clin. Microbiol. Antimicrob.20131213810.1186/1476‑0711‑12‑3824321187
     [Google Scholar]
  19. WarrenJ.W. AbrutynE. HebelJ.R. JohnsonJ.R. SchaefferA.J. StammW.E. Infectious Diseases Society of America (IDSA) Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women.Clin. Infect. Dis.199929474575810.1086/52042710589881
     [Google Scholar]
  20. ICMR Treatment Guidelines for Antimicrobial Use in Common Syndromes.IndiaIndian Council of Medical Research Department of Health Research New Delhi2019
     [Google Scholar]
  21. ZhongZ.X. CuiZ.H. LiX.J. TangT. ZhengZ.J. NiW.N. FangL.X. ZhouY.F. YuY. LiuY.H. LiaoX.P. SunJ. Nitrofurantoin combined with Amikacin: A promising alternative strategy for combating MDR uropathogenic Escherichia coli. Front. Cell. Infect. Microbiol.2020101260854710.3389/fcimb.2020.60854733409159
     [Google Scholar]
  22. HuttnerA. VerhaeghE.M. HarbarthS. MullerA.E. TheuretzbacherU. MoutonJ.W. Nitrofurantoin revisited: A systematic review and meta-analysis of controlled trials.J. Antimicrob. Chemother.20157092456246410.1093/jac/dkv14726066581
     [Google Scholar]
  23. GardinerB.J. StewardsonA.J. AbbottI.J. PelegA.Y. Nitrofurantoin and fosfomycin for resistant urinary tract infections: Old drugs for emerging problems.Aust. Prescr.2019421141910.18773/austprescr.2019.00230765904
     [Google Scholar]
  24. TammaP.D. AitkenS.L. BonomoR.A. MathersA.J. van DuinD. ClancyC.J. Infectious Diseases Society of America 2022 Guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR- P. aeruginosa ).Clin. Infect. Dis.202275218721210.1093/cid/ciac26835439291
     [Google Scholar]
  25. MallyaA. VijayganapathyS. KarthikeyanV.S. MythriK. ViswanathaR. KeshavamurthyR. Antimicrobial resistance patterns in a tertiary care nephro-urology center in South India.J. Integ. Nephrol. Androl.2018539310.4103/jina.jina_16_17
     [Google Scholar]
  26. NCID One Health Report on Antimicrobial Use & Antimicrobial Resistance.SingaporeOne Health Antimicrobial Resistance Workgroup2017
     [Google Scholar]
  27. SahB.K. DahalP. MallikS.K. PaulA.D. MainaliU. ShahC. DahalP. Uropathogens and their antimicrobial-resistant pattern among suspected urinary tract infections patients in eastern Nepal: A hospital inpatients-based study.SAGE Open Med.2023112050312123122082110.1177/2050312123122082138148764
     [Google Scholar]
  28. EjerssaA.W. GadisaD.A. OrjinoT.A. Prevalence of bacterial uropathogens and their antimicrobial susceptibility patterns among pregnant women in Eastern Ethiopia: Hospital-based cross-sectional study.BMC Womens Health202121129110.1186/s12905‑021‑01439‑634364376
     [Google Scholar]
  29. DasguptaC. RafiM.A. SalamM.A. High prevalence of multidrug resistant uropathogens: A recent audit of antimicrobial susceptibility testing from a tertiary care hospital in Bangladesh.Pak. J. Med. Sci.20203661297130210.12669/pjms.36.6.294332968397
     [Google Scholar]
/content/journals/nemj/10.2174/0102506882361055250328081507
Loading
A Study on Bacterial Urinary Tract Infections, Antibiogram, and Antimicrobial Practices among Healthcare Providers in a Tertiary Care Facility in India
NEW Emirates Medical J 5, E02506882361055 (2024); https://doi.org/10.2174/0102506882361055250328081507
/content/journals/nemj/10.2174/0102506882361055250328081507
/content/journals/nemj/10.2174/0102506882361055250328081507
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Antibiogram; Antibiotic practices; Health care providers; Sensitivity; Urinary tract infections; Uropathogens; Urosepsis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test